Literature DB >> 11168601

Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately.

W M Mulleners1, S K Aurora, E P Chronicle, R Stewart, S Gopal, P J Koehler.   

Abstract

OBJECTIVES: To assess the reliability of self-reported photophobia across different patient populations and to examine how visual stress thresholds and photophobic symptoms may be predictive of diagnosis.
BACKGROUND: Relatively little is known about interictal photophobia in migraine. In particular, the variability of photophobia across different patient groups has not previously been studied, and a pathophysiological hypothesis to account for the symptoms is not agreed upon. METHODS AND
RESULTS: Study 1 compared 99 self-selected Dutch patients and 101 headache-free controls using survey methods. Patients both with and without aura were significantly more likely to report symptoms, such as the wearing of sunglasses in normal daylight, consistent with interictal photophobia. Study 2 replicated these findings in a series of consecutive referrals to a headache clinic in the United States. Study 3 used a specially designed laboratory test to examine the threshold for visual stress in those patients who had participated in study 2. Visual stress thresholds were significantly lower in patients than in controls. A discriminant function analysis of data from both studies 2 and 3 showed that diagnostic category (migraine; control) could be predicted from photophobic symptoms and visual stress thresholds at a level significantly better than chance.
CONCLUSIONS: We suggest that interictal photophobia is common in migraine and similar across different patient populations. One pathophysiological hypothesis is that interictal photophobia is associated with cortical hypersensitivity to stimulation. The predictive validity of interictal photophobic symptoms suggests that clinical diagnosis may be aided by questioning the patient about light sensitivity in the period between attacks.

Entities:  

Mesh:

Year:  2001        PMID: 11168601     DOI: 10.1046/j.1526-4610.2001.111006031.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  22 in total

1.  Arctic environment triggers migraine attacks.

Authors:  Hallvard Lilleng; Svein Ivar Bekkelund
Journal:  Can Fam Physician       Date:  2010-06       Impact factor: 3.275

2.  Sensitivity and specificity of the new international diagnostic criteria for migraine with aura.

Authors:  M K Eriksen; L L Thomsen; J Olesen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

Review 3.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 4.  Primary headache disorders and neuro-ophthalmologic manifestations.

Authors:  Daniel P Schwartz; Matthew S Robbins
Journal:  Eye Brain       Date:  2012-09-13

5.  A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.

Authors:  Andrew F Russo; Adisa Kuburas; Eric A Kaiser; Ann C Raddant; Ana Recober
Journal:  Mol Cell Pharmacol       Date:  2009

6.  Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.

Authors:  Ana Recober; Eric A Kaiser; Adisa Kuburas; Andrew F Russo
Journal:  Neuropharmacology       Date:  2009-07-14       Impact factor: 5.250

7.  Migraine strikes study: factors in patients' decision to treat early.

Authors:  Wendy Golden; Judith K Evans; Henry Hu
Journal:  J Headache Pain       Date:  2009-01-10       Impact factor: 7.277

Review 8.  CGRP in Animal Models of Migraine.

Authors:  Anne-Sophie Wattiez; Mengya Wang; Andrew F Russo
Journal:  Handb Exp Pharmacol       Date:  2019

9.  Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine.

Authors:  Ana Recober; Adisa Kuburas; Zhongming Zhang; John A Wemmie; Michael G Anderson; Andrew F Russo
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

10.  GERD prevalence in migraine patients and the implication for acute migraine treatment.

Authors:  Bozena J Katić; Wendy Golden; Roger K Cady; X Henry Hu
Journal:  J Headache Pain       Date:  2008-11-14       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.